News Quantified

AXNX – axonics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Axonics did not infringe Medtronic's patents, jury rules [Yahoo! Finance]

Axonics Prevails in Patent Infringement Lawsuit with Medtronic [Yahoo! Finance]

Axonics Prevails in Patent Infringement Lawsuit with Medtronic

Axonics gains after win in trial in patent dispute with Medtronic [Seeking Alpha]

Axonics, Inc. (NASDAQ: AXNX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.

0.2%

BEAT

3.5%

BEAT

Needham & Company LLC

Form 10-Q Axonics, Inc. For: Jun 30

Form 8-K Axonics, Inc. For: Aug 01

Form 4 Axonics, Inc. For: Jul 24 Filed by: COHEN RAYMOND W

Top News Gainers

1/9 Axonics® Announces Preliminary Fourth Quarter and Full Year 2019 Revenue 20.8%

5/8 Q1/2019 3/31/2019 EPS -0.470 ZacksConsensus -0.400 ActVsEst (0.070) - Miss 19.5%

4/16 Form 8-K Axonics Modulation Techn For: Apr 16 13.3%

8/6 Form 4 Axonics Modulation Techn For: Aug 06 Filed by: COHEN RAYMOND W 10.3%

4/6 Axonics® Submits PMA Supplement to U.S. Food & Drug Administration to Expand Full-Body MRI Labeling for 3T Scans 9.7%

3/18 Form 4 Axonics Modulation Techn For: Mar 16 Filed by: COHEN RAYMOND W 8.8%

4/6 Form 4 Axonics Modulation Techn For: Apr 02 Filed by: Sama Rinda 8.3%

11/14 Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System for Urinary Clinical Indications 8.2%

4/14 Axonics® Announces U.S. Food & Drug Administration Approval of Next Generation Implantable Neurostimulator 7.1%

6/13 Axonics Modulation Technologies Inc (NASDAQ: AXNX) had its price target raised by analysts at Bank of America Corp from $30.00 to $35.00. They now have a "buy" rating on the stock. 6.8%

Top News Decliners

3/16 Axonics® Announces Filing of Petitions Before the United States Patent and Trademark Office Contesting the Validity of Medtronic Patents -21.0%

11/17 Axonics Modulation Technlogs INC (AXNX) Q3 2019 Earnings Call Transcript [The Motley Fool] -12.4%

3/9 Axonics Modulation Technologies Inc (NASDAQ: AXNX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $48.00 price target on the stock. -10.0%

8/5 Axonics® Announces Second Quarter 2019 Financial Results and Operational Update -8.7%

3/4 Form 8-K Axonics Modulation Techn For: Mar 04 -8.0%

10/7 Axonics® Broadens EU Commercial Footprint with Recommendation for Reimbursement in France and Supply Contract in Norway -7.9%

9/9 Form 8-K Axonics Modulation Techn For: Sep 09 -7.8%

11/6 Form S-3 Axonics Modulation Techn -7.8%

11/14 Form 10-Q Axonics Modulation Techn For: Sep 30 -7.8%

4/21 Axonics Modulation Technologies Inc (NASDAQ: AXNX) had its price target lowered by analysts at Piper Sandler from $48.00 to $44.00. They now have an "overweight" rating on the stock. -7.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day